Advanced Medicine

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.

What are the key decisions that need to be made for cell therapy supply chains?

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

How pharmaceutical therapeutics are expanding into a whole new galaxy of options.

We want to hear your thoughts on what mRNA could do for cell and gene therapy

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.